Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
60
KYMR Quote, Financials, Valuation and Earnings
Last price:
$46.20
Seasonality move
:
-8.02%
Day range:
$45.59 - $46.93
52-week range:
$19.45 - $53.27
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
60.91x
P/B ratio:
3.84x
Volume:
421.3K
Avg. volume:
859.3K
1-year change:
-1.05%
Market cap:
$3B
Revenue:
$47.1M
EPS (TTM):
-$3.10
Earnings Data
Next earnings date for KYMR
Aug 07
2025
Most recent earnings per share
-$0.82
Beat by $0.09
(May 9/2025)
Consensus Estimate
-$0.91
(May 9/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
KYMR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $15.7M | -- | -- | -$0.90 | -- |
| 08/07/2025 | Q2 | $23.5M | -- | -- | -$0.80 | -- |
| 05/09/2025 | Q1 | $10.7M | $22.1M | -$0.82 | -$0.91 | $0.09 |
| 02/27/2025 | Q4 | $14.8M | $7.4M | -$0.88 | -$0.79 | -$0.09 |
| 10/31/2024 | Q3 | $10.3M | $3.7M | -$0.82 | -$0.84 | $0.02 |
| 08/07/2024 | Q2 | $12.6M | $25.7M | -$0.58 | -$0.66 | $0.08 |
| 05/02/2024 | Q1 | $13.1M | $10.3M | -$0.69 | -$0.72 | $0.03 |
| 02/22/2024 | Q4 | $42M | $47.9M | -$0.25 | -$0.38 | $0.13 |
| 11/02/2023 | Q3 | -- | -- | -$0.90 | -$0.70 | -$0.20 |
| 08/03/2023 | Q2 | -- | -- | -$0.67 | -$0.74 | $0.07 |
| 05/04/2023 | Q1 | -- | -- | -$0.70 | -$0.69 | -$0.01 |
| 02/23/2023 | Q4 | -- | -- | -$0.60 | -$0.63 | $0.03 |
| 11/03/2022 | Q3 | -- | -- | -$0.79 | -$0.75 | -$0.04 |
| 08/09/2022 | Q2 | -- | -- | -$0.78 | -$0.69 | -$0.09 |
| 05/03/2022 | Q1 | -- | -- | -$0.71 | -$0.67 | -$0.04 |
| 02/24/2022 | Q4 | -- | -- | -$0.66 | -$0.57 | -$0.09 |
| 11/10/2021 | Q3 | -- | -- | -$0.56 | -$0.37 | -$0.19 |
| 08/06/2021 | Q2 | -- | -- | -$0.55 | -$0.25 | -$0.30 |
| 05/06/2021 | Q1 | -- | -- | -$0.29 | -$0.20 | -$0.09 |
| 03/11/2021 | Q4 | -- | -- | -$0.29 | -$0.14 | -$0.15 |
| 11/05/2020 | Q3 | -- | -- | -$0.39 | $2.91 | -$3.30 |
| 06/30/2020 | Q2 | -- | -- | -$0.34 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.38 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.38 | -- | -- |
Kymera Therapeutics Earnings Questions
-
How Much did Kymera Therapeutics Generate in Revenue Last Quarter?
Kymera Therapeutics reported $22.1M worth of top line sales in its most recent quarter.
-
Did Kymera Therapeutics Beat Earnings Last Quarter?
Kymera Therapeutics announced earnings per share of -$0.82 which represents a beat of analyst forecast a -$0.91 per share.
-
Is Kymera Therapeutics Profitable?
Kymera Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Kymera Therapeutics EPS Next Year?
Kymera Therapeutics's earnings are forecast to decrease from -$2.98 per share to -$2.84 per share next year representing a decrease of -22.41%.
-
When is Kymera Therapeutics's Earnings Date?
Kymera Therapeutics's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 11.86% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 5.56% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.31% over the past day.
